Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

PURPOSE: The optimal treatment for patients with low to early-intermediate risk prostate cancer (PCa) remains to be defined. The randomized PREFERE trial (DRKS00004405) aimed to assess noninferiority of active surveillance (AS), external-beam radiotherapy (EBRT), or brachytherapy by permanent seed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegel, Thomas, Albers, Peter, Bartkowiak, Detlef, Bussar-Maatz, Roswitha, Härter, Martin, Kristiansen, Glen, Martus, Peter, Wellek, Stefan, Schmidberger, Heinz, Grozinger, Klaus, Renner, Peter, Schneider, Fried, Burmester, Martin, Stöckle, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810635/
https://www.ncbi.nlm.nih.gov/pubmed/32886212
http://dx.doi.org/10.1007/s00432-020-03327-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810635/
https://www.ncbi.nlm.nih.gov/pubmed/32886212
http://dx.doi.org/10.1007/s00432-020-03327-2

Ejemplares similares